Pluristem Therapeutics Inc., a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient cell therapy products for a variety of disorders, announced today that it will be presenting the Company's development program at 9 am on Wednesday, April 22, 2009 at the Stock Exchange in Tel Aviv, Israel.
24994
Pluristem Therapeutics to present at the Tel-Aviv Stock Exchange
52550
Corcept Therapeutics submits NDA for the use of Corlux in Cushing's Syndrome
12617
Alchemia to spin off oncology business
75625
Genzyme faces production delays for key drugs
51501
ZymoGenetics offering $79 million in common stock
67830
Scientists use stem cells to reverse symptoms of multiple sclerosis
127712
Stem cell research used to create human kidney
19590
Generex Biotechnology comments on recent trading activity
105472
ResMed Inc. to present at upcoming conferences
137699
3D breakthrough in growing organs
84051
Plexxikon initiates Phase 1 trial for PLX5568
90632
Scientists discover potential drug delivery system
69958
Alimera Sciences resubmits new drug application
91984
Researchers developing new methods to treat advanced prostate cancer
107313
Paragon software Group and MTS announce ?
159811
Beckman Coulter, Inc. to distribute CompuCyte laser scanning cytometers
148920
Medical device startup raises $13.1 million